Big Interview: Square Health's Dr Bippon Vinayak

clock • 11 min read

Fiona Murphy talks to Dr. Bippon Vinayak about why he launched Square Health, his plans for working with the protection industry, speeding up the screening process through IFAs and how his background in plastic surgery earned him the nickname 'the Rhinoplasty King.'

FM: Before we discuss Square Health, can you tell me about its parent company the Doctors Chambers group? BV: Doctors Chambers was formed by a group of five doctors working in Oxford back in 1994 and we formed a group that provided medical advice to solicitors on cases of criminal negligence, so we were acting a bit like barristers here, hence the name.  We thought we'd call ourselves Doctors Chambers, like a barrister's chambers would, and that was really what we did for the first year or so. The business grew gradually to deal with big court cases beyond criminal negligence. Also...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

Third of adults are not confident on coping with financial shocks

Third of adults are not confident on coping with financial shocks

The Exeter research findings

Jaskeet Briah
clock 24 June 2026 • 2 min read
Beagle Street enters intermediary market

Beagle Street enters intermediary market

Life and CI

Cameron Roberts
clock 19 June 2026 • 3 min read
CIC claims for prostate cancer up by 65% since 2023: Aviva

CIC claims for prostate cancer up by 65% since 2023: Aviva

£38m paid out for prostate cancer in 2025

Jaskeet Briah
clock 15 June 2026 • 1 min read